Form 4: Amgen EVP Jonathan P. Graham Reports Acquisition of 6,306 Shares of Common Stock

Jonathan P. Graham, EVP & General Counsel & Secretary of Amgen Inc., reports acquiring 6,306 shares of common stock on March 3, 2025.

Summary

• On March 3, 2025, Jonathan P. Graham, an Executive Vice President, General Counsel, and Secretary at Amgen Inc., acquired 6,306 shares of Amgen's common stock.
• The acquisition was a direct transaction.
• Following the transaction, Graham directly owns 35,293 shares of Amgen common stock.
• The acquired shares include 634 Dividend Equivalents (DEs) granted pursuant to the Amgen Inc. Second Amended and Restated 2009 Equity Incentive Plan and subject to a qualifying dividend reinvestment plan.

Sentiment

Score: 5

Explanation: The sentiment is neutral as it's a standard disclosure of stock acquisition by an executive. It doesn't inherently indicate positive or negative sentiment about the company's performance.

Positives

• The acquisition of shares by a company executive can be seen as a positive signal, indicating confidence in the company's future prospects.

Industry Context

Form 4 filings are a routine part of insider trading regulations, providing transparency into the transactions of company executives and directors.

Stakeholder Impact

• The acquisition of shares by an executive may have a minor positive impact on shareholder sentiment.

Key Dates